Nervonik, Inc. Raises $52.5 Million for Advanced Nerve Stimulation Technologies

Nervonik, Inc. concludes oversubscribed Series B financing round to develop next-generation peripheral nerve stimulation technologies.

AI-assisted, human-published

Latest headlines

Join us for funding and investment opportunities.

Stay connected!

If you have a serious, bonafide inquiry into the VentureCapital.com or PrivateEquity.com domain names, please contact us here